Satisfai Health receives FDA Breakthrough Device Designation for analysis of Barrett's Esophagus and Early Esophageal Cancer with its Artificial Intelligence tool, 'Veritai', during endoscopy. Advanced real-time clinical diagnostics at the point of care to help detect early and treatable cancer in millions of people around the globe.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: